Kakehi Y - Search Results

1

Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.

Wang J, Zhao LY, Uyama T, Tsuboi K, Wu XX, Kakehi Y, Ueda N. Wang J, et al. Among authors: kakehi y. J Biochem. 2008 Nov;144(5):685-90. doi: 10.1093/jb/mvn122. Epub 2008 Sep 19. J Biochem. 2008. PMID: 18806270

2

Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.

Wu XX, Kakehi Y, Takahashi T, Habuchi T, Ogawa O. Wu XX, et al. Among authors: kakehi y. Int J Urol. 2000 Jun;7(6):210-7. doi: 10.1046/j.1442-2042.2000.00178.x. Int J Urol. 2000. PMID: 10843452 Free article. Clinical Trial.

3

Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.

Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O. Wu XX, et al. Among authors: kakehi y. Cancer Res. 2000 Jun 1;60(11):2912-8. Cancer Res. 2000. PMID: 10850437

4

Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.

Lu JJ, Kakehi Y, Takahashi T, Wu XX, Yuasa T, Yoshiki T, Okada Y, Terachi T, Ogawa O. Lu JJ, et al. Among authors: kakehi y. Clin Cancer Res. 2000 Aug;6(8):3166-71. Clin Cancer Res. 2000. PMID: 10955799

5

Increased intracellular doxorubicin by anti-FAS monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells.

Wu X, Kakehi Y, Mizutani Y, Terachi T, Ogawa O. Wu X, et al. Among authors: kakehi y. Urology. 2001 May;57(5):993-8. doi: 10.1016/s0090-4295(01)00947-5. Urology. 2001. PMID: 11337314

6

Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil.

Wu XX, Kakehi Y, Mizutani Y, Lu J, Terachi T, Ogawa O. Wu XX, et al. Among authors: kakehi y. Int J Oncol. 2001 Jul;19(1):19-24. doi: 10.3892/ijo.19.1.19. Int J Oncol. 2001. PMID: 11408917

7

Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.

Wu XX, Kakehi Y, Mizutani Y, Kamoto T, Kinoshita H, Isogawa Y, Terachi T, Ogawa O. Wu XX, et al. Among authors: kakehi y. Int J Oncol. 2002 May;20(5):949-54. Int J Oncol. 2002. PMID: 11956588

8

Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells.

Wu XX, Kakehi Y, Mizutani Y, Nishiyama H, Kamoto T, Megumi Y, Ito N, Ogawa O. Wu XX, et al. Among authors: kakehi y. Int J Cancer. 2003 Apr 20;104(4):409-17. doi: 10.1002/ijc.10948. Int J Cancer. 2003. PMID: 12584736

9

Telomerase activity in urine after transurethral resection is not a predictive marker for recurrence of superficial bladder cancer.

Wu XX, Kakehi Y, Nishiyama H, Habuchi T, Ogawa O. Wu XX, et al. Among authors: kakehi y. Int J Urol. 2003 Feb;10(2):117-8. doi: 10.1046/j.1442-2042.2003.00581.x. Int J Urol. 2003. PMID: 12588612 Free article. No abstract available.

10

Sensitization of human renal cell carcinoma cell lines to TRAIL-induced apoptosis by anthracyclines.

Wu XX, Ogawa O, Kakehi Y. Wu XX, et al. Among authors: kakehi y. Int J Urol. 2004 Mar;11(3):164-70. doi: 10.1111/j.1442-2042.2003.00766.x. Int J Urol. 2004. PMID: 15009365 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters